about
Plasma membrane trafficking in alveolar type II cellsDirect visualization of HIV-enhancing endogenous amyloid fibrils in human semen.Reacquisition of Nef-mediated tetherin antagonism in a single in vivo passage of HIV-1 through its original chimpanzee hostHuman tetherin exerts strong selection pressure on the HIV-1 group N Vpu protein.Liquefaction of semen generates and later degrades a conserved semenogelin peptide that enhances HIV infection.Semen amyloids participate in spermatozoa selection and clearanceNef proteins of epidemic HIV-1 group O strains antagonize human tetherin.Lentiviral Nef proteins manipulate T cells in a subset-specific mannerEfficient Nef-mediated downmodulation of TCR-CD3 and CD28 is associated with high CD4+ T cell counts in viremic HIV-2 infectionA molecular tweezer antagonizes seminal amyloids and HIV infection.The efficiency of Vpx-mediated SAMHD1 antagonism does not correlate with the potency of viral control in HIV-2-infected individuals.2-APB and capsazepine-induced Ca2+ influx stimulates clathrin-dependent endocytosis in alveolar epithelial cells.Atomic force microscopy of microvillous cell surface dynamics at fixed and living alveolar type II cells.Peptide nanofibrils boost retroviral gene transfer and provide a rapid means for concentrating viruses.DOCK8 enforces immunological tolerance by promoting IL-2 signaling and immune synapse formation in Tregs.Bone degradation machinery of osteoclasts: An HIV-1 target that contributes to bone loss.Molecular basis of early epithelial response to streptococcal exotoxin: role of STIM1 and Orai1 proteinsHIV-1 Balances the Fitness Costs and Benefits of Disrupting the Host Cell Actin Cytoskeleton Early after Mucosal TransmissionTargeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy
P50
Q28583618-AC0CF8D3-0F21-46B1-9256-665743F97763Q30360888-F4D9E7C7-C26D-440C-B520-1F0EAC8872ADQ30421288-B49F2A2F-7557-4185-A16D-1DCB9CF89151Q30425799-48615347-A089-4F5D-A4EC-C076D2938732Q33744114-5DF8E00B-DF7B-4044-9952-D43A0DF5969AQ33842506-324501C6-FFBC-41A3-9C0F-50B3D09535B6Q34761549-3DCD463C-5DDB-40C7-8E68-B0493AE44AF6Q35115692-C668082A-3917-4DF3-BB0C-2D45FD0E4DE5Q35943789-96ECA4B6-F812-40CC-B309-586615A57687Q35954283-77B95B10-B01A-4FC1-B73B-DFF6F2C0BA24Q36690419-23A66154-93EB-4E06-B7C1-661924F2E1CAQ39755039-531CA22E-4DDD-465F-8C73-8DA366886AAEQ45912142-943D260F-E796-4515-8E48-48CCFF522A20Q46614290-DA2DD794-81D4-4FF3-B48C-529992554023Q47863316-65BEA8CA-7536-4B4C-B52A-B2AEFC6D336FQ49790704-A58F8181-AD72-4711-8CB0-4020BA59CDFAQ59347820-0FD1E60B-DF18-4BA0-B446-18BDA33EDE08Q90984519-C330DD4D-9EB9-42F3-B7A8-C06EC6F87DAEQ92052884-D9E723B7-80FA-44BC-A96B-A136DD070F57
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Shariq M Usmani
@ast
Shariq M Usmani
@en
Shariq M Usmani
@es
Shariq M Usmani
@nl
type
label
Shariq M Usmani
@ast
Shariq M Usmani
@en
Shariq M Usmani
@es
Shariq M Usmani
@nl
prefLabel
Shariq M Usmani
@ast
Shariq M Usmani
@en
Shariq M Usmani
@es
Shariq M Usmani
@nl
P106
P31
P496
0000-0002-6462-1098